You haven't searched anything yet.
About Aura:
Aura Biosciences is a clinical stage oncology company. We are developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively, while activating the immune system to create long lasting anti-tumor immunity.
We have a goal of developing this technology in multiple cancer indications, focusing initially on two therapeutic areas – ocular oncology and bladder cancer – with a goal to expand into other areas of solid tumor oncology. Initially we have focused our clinical development in the medical field of ocular oncology, a group of rare diseases that have no drugs approved, and in non-muscle invasive and muscle invasive bladder cancer, currently in a Phase 1 trial.
We have commenced a global Phase 3 program investigating the delivery of AU-011 for the treatment of small choroidal melanoma and indeterminate lesions. AU-011 has to date demonstrated an excellent efficacy and safety profile in Phase 2 for choroidal melanoma, and enrolment is ongoing in the pivotal Phase 3.
Position Summary:
Aura Biosciences, Inc. is currently expanding its Clinical Development team to support several early- and late-phase clinical programs and is searching for a highly motivated and hands-on (Sr) Director level Clinical Development Scientist to support the continued development of AU-011 in the treatment of ocular and non-ocular bladder cancers. Aura is developing AU-011 as a biologic/drug-led combination product. This individual will be responsible for supporting the Medical Directors within the Clinical Development function, who are responsible for strategy, design, and oversight of all clinical programs at Aura.
This position reports to the SVP of Oncology Clinical Development.
Essential Functions and Duties:
Skills and Experience
Full Time
$168k-217k (estimate)
05/11/2024
07/09/2024
aurabiosciences.com
Cambridge, MA
<25